Treatment of Sarcoptic Mange in Wombats With Topical Moxidectin

ABSTRACT Sarcoptic mange is a debilitating disease affecting free‐living/wild bare‐nosed wombats (Vombatus ursinus). The disease causes thickening of the skin, pruritus, alopecia and deep fissures in the skin of infected animals, and ultimately death if left untreated. In Australia, there are approv...

Full description

Saved in:
Bibliographic Details
Main Authors: Hayley J. Stannard, Marie B. Wynan, Ray J. Wynan, Amanda Cox, Howard Ralph, Gregory S. Doran
Format: Article
Language:English
Published: Wiley 2024-11-01
Series:Veterinary Medicine and Science
Subjects:
Online Access:https://doi.org/10.1002/vms3.70089
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832593403048624128
author Hayley J. Stannard
Marie B. Wynan
Ray J. Wynan
Amanda Cox
Howard Ralph
Gregory S. Doran
author_facet Hayley J. Stannard
Marie B. Wynan
Ray J. Wynan
Amanda Cox
Howard Ralph
Gregory S. Doran
author_sort Hayley J. Stannard
collection DOAJ
description ABSTRACT Sarcoptic mange is a debilitating disease affecting free‐living/wild bare‐nosed wombats (Vombatus ursinus). The disease causes thickening of the skin, pruritus, alopecia and deep fissures in the skin of infected animals, and ultimately death if left untreated. In Australia, there are approvals from the Australian Pesticides and Veterinary Medicines Authority to use moxidectin for treating sarcoptic mange in bare‐nosed wombats; however, few published literatures document the success of treatment regimens. Two adult male bare‐nosed wombats presented with dermatitis, erythema and crusting of the skin. Evaluation of skin scrapings confirmed the presence of live Sarcoptes scabiei. Both wombats were treated with three 100‐mL doses of moxidectin topically poured on to the dorsal backline approximately 7 days apart. Both animals showed improvement, with skin becoming clear of crusting and dermatitis, and no S. scabiei mites were present on either animal after 2 weeks. Here, we presented two clinical scenarios of sarcoptic mange in wombats that were successfully treated with three 100‐mL doses of moxidectin applied topically. We recommend this treatment be used where wombats can be identified and monitored throughout their recovery.
format Article
id doaj-art-35df69a8da164a7084636b6c83f4116d
institution Kabale University
issn 2053-1095
language English
publishDate 2024-11-01
publisher Wiley
record_format Article
series Veterinary Medicine and Science
spelling doaj-art-35df69a8da164a7084636b6c83f4116d2025-01-20T17:16:45ZengWileyVeterinary Medicine and Science2053-10952024-11-01106n/an/a10.1002/vms3.70089Treatment of Sarcoptic Mange in Wombats With Topical MoxidectinHayley J. Stannard0Marie B. Wynan1Ray J. Wynan2Amanda Cox3Howard Ralph4Gregory S. Doran5School of Agricultural, Environmental and Veterinary Sciences, Charles Sturt University Wagga Wagga New South Wales AustraliaJarake Wildlife Sanctuary Ltd Nimmitabel New South Wales AustraliaJarake Wildlife Sanctuary Ltd Nimmitabel New South Wales AustraliaWombat Protection Society of Australia Tomerong New South Wales AustraliaSouthern Cross Wildlife Care Braidwood New South Wales AustraliaSchool of Agricultural, Environmental and Veterinary Sciences, Charles Sturt University Wagga Wagga New South Wales AustraliaABSTRACT Sarcoptic mange is a debilitating disease affecting free‐living/wild bare‐nosed wombats (Vombatus ursinus). The disease causes thickening of the skin, pruritus, alopecia and deep fissures in the skin of infected animals, and ultimately death if left untreated. In Australia, there are approvals from the Australian Pesticides and Veterinary Medicines Authority to use moxidectin for treating sarcoptic mange in bare‐nosed wombats; however, few published literatures document the success of treatment regimens. Two adult male bare‐nosed wombats presented with dermatitis, erythema and crusting of the skin. Evaluation of skin scrapings confirmed the presence of live Sarcoptes scabiei. Both wombats were treated with three 100‐mL doses of moxidectin topically poured on to the dorsal backline approximately 7 days apart. Both animals showed improvement, with skin becoming clear of crusting and dermatitis, and no S. scabiei mites were present on either animal after 2 weeks. Here, we presented two clinical scenarios of sarcoptic mange in wombats that were successfully treated with three 100‐mL doses of moxidectin applied topically. We recommend this treatment be used where wombats can be identified and monitored throughout their recovery.https://doi.org/10.1002/vms3.70089bare‐nosed wombatcase reporttopical applicationVombatus ursinus
spellingShingle Hayley J. Stannard
Marie B. Wynan
Ray J. Wynan
Amanda Cox
Howard Ralph
Gregory S. Doran
Treatment of Sarcoptic Mange in Wombats With Topical Moxidectin
Veterinary Medicine and Science
bare‐nosed wombat
case report
topical application
Vombatus ursinus
title Treatment of Sarcoptic Mange in Wombats With Topical Moxidectin
title_full Treatment of Sarcoptic Mange in Wombats With Topical Moxidectin
title_fullStr Treatment of Sarcoptic Mange in Wombats With Topical Moxidectin
title_full_unstemmed Treatment of Sarcoptic Mange in Wombats With Topical Moxidectin
title_short Treatment of Sarcoptic Mange in Wombats With Topical Moxidectin
title_sort treatment of sarcoptic mange in wombats with topical moxidectin
topic bare‐nosed wombat
case report
topical application
Vombatus ursinus
url https://doi.org/10.1002/vms3.70089
work_keys_str_mv AT hayleyjstannard treatmentofsarcopticmangeinwombatswithtopicalmoxidectin
AT mariebwynan treatmentofsarcopticmangeinwombatswithtopicalmoxidectin
AT rayjwynan treatmentofsarcopticmangeinwombatswithtopicalmoxidectin
AT amandacox treatmentofsarcopticmangeinwombatswithtopicalmoxidectin
AT howardralph treatmentofsarcopticmangeinwombatswithtopicalmoxidectin
AT gregorysdoran treatmentofsarcopticmangeinwombatswithtopicalmoxidectin